Answers are grounded in this paper and cite their sources.
Chordoma is a rare bone cancer originating from the residual notochord and overexpressing the nuclear transcription factor, brachyury, for which a positive immunostaining is a diagnostic hallmark. Patients, most commonly adult males in the fifth to sixth decade of life, usually present with an axial mass in the sacral region. Common symptoms are reflective of the site of involvement, including back pain and neuropathy. Complete surgical resection is the mainstay of treatment of localized chordomas. However, these tumors can be highly aggressive and metastasize to visceral organs, lymph nodes, and the peritoneum, often harboring a poor prognosis. This case report discusses a 46-year-old male with a sacral chordoma that was initially treated with suboptimal resection and eventually metastasized to regional lymph nodes and peritoneum after 5 years. The subsequent management heavily relied on an oncologic multidisciplinary tumor board and involved complete resection of the primary tumor and regional lymph nodes with metastasectomy of the involved peritoneal deposits, providing a favorable patient outcome.
No takes yet. Share an insight, caveat, or question.
Ali Samkari (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: